Riskpilot← Back to searchSign inGet full accessCURES AND PROTECT BY ØFELDT ApS
APSActiveCVR 33368410Vagtelvej 16All other professional, scientific and technical activities n.e.c. · NACE 7499Est. 2010— employees
Revenue 2024
DKK 0
EBITDA margin
—
Equity ratio
-140.8%
Financial strength
Net profit 2024
DKK -14K
-1% vs 2023
| Revenue | DKK 0 | — |
| EBITDA | DKK -82 | — |
| Net profit | DKK -14K | -1% |
| Total assets | DKK 91K | -13% |
| Equity | DKK -128K | -12% |
| Employees | — | — |
Legal name
CURES AND PROTECT BY ØFELDT ApS
CVR number
33368410
Legal form
Anpartsselskab
NACE code
7499 · All other professional, scientific and technical activities n.e.c.
Founded
15. december 2010
Share capital
DKK 80.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er, med udgangspunkt i Øfeldt Metoden®, at forebygge bevægeapparatsgener hos befolkningen, bl.a. via udvikling af træningsudstyr og instruktion/vejledning samt anden virksomhed, som er nuturligt forbundet hermed.
Address
Vagtelvej 16
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -0 | -0 | -0 | 0 | -0 |
| Depreciation & amort. | -15 | -15 | -13 | -13 | -13 |
| EBIT | -15 | -15 | -13 | -13 | -13 |
| Net financials | 0 | -0 | -1 | -1 | -1 |
| Profit before tax | -15 | -15 | -14 | -14 | -14 |
| Tax | -0 | -0 | -0 | -0 | -0 |
| Net profit | -15 | -15 | -14 | -14 | -14 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 144 | 129 | 118 | 104 | 91 |
| Equity | -71 | -86 | -100 | -114 | -128 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 216 | 216 | 218 | 218 | 219 |
| Total debt | 216 | 216 | 218 | 218 | 219 |
EBITDA margin
-8200.0%
This company
15.8%
Market median
-51999% vs market
20202024
Equity ratio
-140.8%
This company
38.2%
Market median
-469% vs market
20202024
Return on equity
-1409700.0%
This company
18.4%
Market median
-7661513% vs market
20202024
Net profit margin
-1409700.0%
This company
8.1%
Market median
-17403804% vs market
20202024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20202024
Debt / equity
1.71×
This company
0.62×
Market median
-176% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AØ Chief Executive Officer | Chief Executive Officer | 2010 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50–66.65% | 50–66.65% | 2010 | |
| Company | 50–66.65% | 50–66.65% | 2010 | |
| Individual | 50–66.65% | 50% | 2010 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ALEX ØFELDT HOLDING ApS
CURES AND PROTECT BY ØFELDT ApS Board members of CURES AND PROTECT BY ØFELDT ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Alex Øfeldt | Chief Executive Officer | 0 companies |